72346-25-9 Usage
Classification
Synthetic nucleoside analogue.
Properties
Antiviral.
Mechanism of action
Inhibits the replication of a wide range of RNA and DNA viruses by interfering with their RNA-dependent RNA polymerase and DNA polymerase enzymes.
Primary uses
Treatment of hepatitis C, respiratory syncytial virus (RSV) infection, and certain viral hemorrhagic fevers.
Available forms
Oral capsules, tablets, and injections.
Side effects
Hemolytic anemia, teratogenicity, and birth defects.
Precaution
Use under the supervision of a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 72346-25-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,3,4 and 6 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 72346-25:
(7*7)+(6*2)+(5*3)+(4*4)+(3*6)+(2*2)+(1*5)=119
119 % 10 = 9
So 72346-25-9 is a valid CAS Registry Number.
72346-25-9Relevant articles and documents
Autofluorescent fused-pyrimidine nucleosides: Synthesis and evaluation as permeants and inhibitors of human nucleoside transporters
Nowak, Ireneusz,Damaraju, Vijaya L.,Cass, Carol E.,Young, James D.,Robins, Morris J.
, p. 1395 - 1412 (2012/04/17)
Nucleosides with an aromatic five-membered ring heterocycle (N, O, or S) fused at C4-C5 of pyrimidin-2-one were prepared by ring closures with 5-(alkyn-1-yl)pyrimidin-2-one intermediates, heterocyclic atom replacements, and ring closure with a 5-aminocyti
